Inventor · disambiguated record
Otis C. Addington
Also filed as: ADDINGTON OTIS C · ADDINGTON OTIS CRANDELL
28 granted patents·5 pending applications·272 citations·filing 2008–2022
96Inventor score
Top patents by PatentIndex Score
33 records- 0198US10729735B1Method and compostitions for treating coronavirus infectionPHOENIX BIOTECHNOLOGY INC·Filed 2020·Granted Aug 4, 2020·26 cites·27 claims
- 0295US9358293B2Method of treating neurological conditions with oleandrinPHOENIX BIOTECHNOLOGY INC·Filed 2013·Granted Jun 7, 2016·25 cites·37 claims
- 0395US9220778B2Method of treating neurological conditions with oleandrin-containing extractPHOENIX BIOTECHNOLOGY INC·Filed 2013·Granted Dec 29, 2015·25 cites·28 claims
- 0494US9877979B2Method of treating neurological conditions with oleandrinPHOENIX BIOTECHNOLOGY INC·Filed 2016·Granted Jan 30, 2018·13 cites·25 claims
- 0594US8481086B2Method of treating neurological conditions with cardiac glycosideADDINGTON OTIS C·Filed 2011·Granted Jul 9, 2013·27 cites·14 claims
- 0694US8394434B2SCF extract containing cardiac glycosideADDINGTON OTIS CRANDELL·Filed 2012·Granted Mar 12, 2013·31 cites·30 claims
- 0794US8187644B2SCF extract containing cardiac glycosideADDINGTON OTIS CRANDELL·Filed 2008·Granted May 29, 2012·36 cites·13 claims
- 0893US10226497B2Composition for and method of treating neurological conditionsPHOENIX BIOTECHNOLOGY INC·Filed 2017·Granted Mar 12, 2019·10 cites·13 claims
- 0993US9494589B2Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycosidePHOENIX BIOTECHNOLOGY INC·Filed 2015·Granted Nov 15, 2016·15 cites·44 claims
- 1093US9011937B2Method of treating neurological conditions with extract of Nerium species or Thevetia speciesADDINGTON OTIS C·Filed 2011·Granted Apr 21, 2015·23 cites·30 claims
- 1192US10307450B2Method of treating neurological conditions with extract of Nerium species or Thevetia speciesPHOENIX BIOTECHNOLOGY INC·Filed 2017·Granted Jun 4, 2019·4 cites·18 claims
- 1292US8367363B2Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycosidePHOENIX BIOTECHNOLOGY INC·Filed 2010·Granted Feb 5, 2013·20 cites·54 claims
- 1386US11123387B2Method and compositions for treating viral infectionPHOENIX BIOTECHNOLOGY INC·Filed 2020·Granted Sep 21, 2021·1 cites·11 claims
- 1486US11013776B2Method and compositions for treating viral infectionPHOENIX BIOTECHNOLOGY INC·Filed 2020·Granted May 25, 2021·1 cites·18 claims
- 1585US11007239B2Method and compositions for treating viral infectionPHOENIX BIOTECHNOLOGY INC·Filed 2020·Granted May 18, 2021·1 cites·26 claims
- 1685US10980852B2Method and compositions for treating viral infectionPHOENIX BIOTECHNOLOGY INC·Filed 2020·Granted Apr 20, 2021·1 cites·29 claims
- 1785US10874704B2Method and compositions for treating viral infectionPHOENIX BIOTECHNOLOGY INC·Filed 2020·Granted Dec 29, 2020·1 cites·21 claims
- 1885US10596186B2Method and compositions for treating viral infectionsPHOENIX BIOTECHNOLOGY INC·Filed 2019·Granted Mar 24, 2020·4 cites·33 claims
- 1983US10702567B2Method and compositions for treating viral infectionPHOENIX BIOTECHNOLOGY INC·Filed 2019·Granted Jul 7, 2020·1 cites·20 claims
- 2083US9846156B2Method of treatment employing cardiac glycosidePHOENIX BIOTECHNOLOGY INC·Filed 2016·Granted Dec 19, 2017·3 cites·29 claims
- 2180US11324789B2Method and compositions for treating equine encephalitisPHOENIX BIOTECHNOLOGY INC·Filed 2021·Granted May 10, 2022·0 cites·23 claims
- 2280US10973785B2Method of and improved composition for treating triterpene-responsive conditions, diseases or disordersPHOENIX BIOTECHNOLOGY INC·Filed 2020·Granted Apr 13, 2021·1 cites·14 claims
- 2380US10383886B2Method of treating neurological conditions with oleandrinPHOENIX BIOTECHNOLOGY INC·Filed 2017·Granted Aug 20, 2019·1 cites·32 claims
- 2477US10722482B2Method of and improved composition for treating triterpene-responsive conditions, diseases or disordersPHOENIX BIOTECHNOLOGY INC·Filed 2018·Granted Jul 28, 2020·2 cites·15 claims
- 2570US12097234B2Extract containing oleandrin and method of production thereofPHOENIX BIOTECHNOLOGY INC·Filed 2022·Granted Sep 24, 2024·0 cites·29 claims
- 2670US10960037B2Method of treating neurological conditions with extract of Nerium species or Thevetia speciesPHOENIX BIOTECHNOLOGY INC·Filed 2019·Granted Mar 30, 2021·0 cites·23 claims
- 2767US11806359B2Method and compositions for treating Coronavirus infectionPHOENIX BIOTECHNOLOGY INC·Filed 2021·Granted Nov 7, 2023·0 cites·13 claims
- 2860US2022362275A1Method and Compositions for Treating GlioblastomaPHOENIX BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 2959US2022047616A1Method and Compositions for Treating HTLV-1 Virus InfectionPHOENIX BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 3058US2013324485A1Method of Determining the Probability of a Therapeutic Response in Cancer Chemotherapy with Cardiac GlycosidePHOENIX BIOTECHNOLOGY INC·Filed 2013·Application pending·0 cites
- 3158US2022054521A1Method and Compositions for Treating Coronavirus InfectionPHOENIX BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 3251US11331291B2Method of and improved composition for treating triterpene-responsive conditions, diseases or disordersPHOENIX BIOTECHNOLOGY INC·Filed 2021·Granted May 17, 2022·0 cites·13 claims
- 3347US2015283191A1Method of Treating Neurological Conditions with Extract of Nerium Species or Thevetia SpeciesPHOENIX BIOTECHNOLOGY INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Otis C. Addington files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →